Simplify Asset Management Inc. Atri Cure, Inc. Transaction History

Simplify Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $5,386 - $7,562	-131 Reduced 1.12%	11,519 $504,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $116,548 - $142,947	2,882 Added 32.87%	11,650 $575,000
Q1 2023 May 10, 2023	SELL	$35.87 - $47.22 $93,979 - $123,716	-2,620 Reduced 23.01%	8,768 $363,000
Q4 2022 Feb 10, 2023	BUY	$33.48 - $47.45 $30,701 - $43,511	917 Added 8.76%	11,388 $505,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $125,268 - $172,330	3,275 Added 45.51%	10,471 $409,000
Q2 2022 Aug 11, 2022	SELL	$35.1 - $66.01 $121,375 - $228,262	-3,458 Reduced 32.46%	7,196 $294,000
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $305,757 - $380,080	5,324 Added 99.89%	10,654 $700,000
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $337,922 - $464,456	5,330 New	5,330 $371,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.